Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | Progress in ALL & trends in the survival of young adult patients in Sweden and the USA

Magnus Björkholm • 15 Mar 2019
ISAL 2019
Acute Lymphoblastic Leukemia Leukemia

Magnus Björkholm, MD, PhD, of the Karolinska Institute, Stockholm, Sweden, speaks at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany. He discusses the trends in survival of young adult patients with acute lymphoblastic leukemia (ALL) in Sweden and the USA, including the aims behind this work and possible reasons for the results seen.

More from Magnus Björkholm

2:14
Key population-based registry studies in hematological oncology
Magnus Björkholm • 15 Mar 2019

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals